Provider review
Medivive review
Argues against the membership model with figures rather than adjectives.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
We may earn a commission at no extra cost to you. Affiliate partners are listed first on our rankings. How we’re funded.
$162/mo all-in, with the medication inside the figure
Visit MediviveThe structure it describes genuinely exists, though it names no seller.
Price as published
Medivive
$162/mo all-in, with the medication inside the figure
- Vs median
- $13/mo below the $175 median
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
The argument here is made with numbers instead of adjectives, which is unusual enough to be the reason to read this review. Rather than claiming to be transparent, the page describes the structure it says other programs use — a small charge to start, then a substantial monthly fee purely to remain a member — attaches figures to both halves of it, and states plainly that it does neither. That is checkable in the way that matters: you can hold those numbers up against other providers and see whether the pattern described is real. It is; that structure appears repeatedly in this category. What the page does not do is name anybody, so this is a description of a pattern rather than an accusation about a company, which is the right side of the line to be on. Its own figure is all-in with the medication inside it, which is the claim that matters most, and it is a floor rather than a rate. No milligram appears.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You have been caught by a membership fee that bought no medication
- You want the medication explicitly inside the advertised figure
- You want a seller to describe what it is not doing, with numbers
Look elsewhere if
- You want a rate rather than a starting point
- You want the comparison attributed to named providers
- You want a dose behind the number
What it actually costs
Price as published
$162/mo all-in, with the medication inside the figure
- Vs median
- $13/mo below the $175 median across the 299 of 548 programs here that publish a plain monthly rate
- Market
- $59–$1,300/mo is the full published spread on this site
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
235 of the 548 programs here price a small dose this way. Argues its case with figures rather than adjectives: it describes the joining-fee-plus-membership structure it says others run, attaches numbers to both halves, and states that its own price is all-in with the medication inside it. The structure it describes genuinely exists elsewhere, so the comparison is checkable as a pattern even though no seller is named. Its own figure is a floor; no low-dose product and no dose published.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not confirmed
- Labs
- Not required
- Pricing
- Check plan terms
What it does well
- Describes the competing fee structure with figures rather than adjectives.
- The medication is explicitly inside the all-in price.
- States a zero membership fee rather than leaving membership unmentioned.
Pharmacy, labs and oversight
Medivive does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
2 of 4 published openly
What Medivive publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere on its own pages.
- Not published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
The argument here is made with numbers rather than adjectives, which is unusual. Instead of claiming to be transparent, the page describes the structure it says others use — a small charge to start, then a substantial monthly fee just to remain a member — attaches figures to both halves, and states that it does neither. That is checkable in the sense that matters: a reader can hold those numbers up against other providers and see whether the structure described is real. It is. What the page does not do is name anybody, so the comparison is a description of a pattern rather than an accusation about a company. Its own figure is all-in with the medication inside it, which is the claim that matters most, and it is a floor rather than a rate. No milligram appears.
The honest cons
The figure is a floor with nothing above it published.
- The competing structure it describes is attributed to no particular seller.
- No milligram appears against the figure.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
Medivive is one of 548 low-dose GLP-1 programs compared on this site, and 299 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.
Also consider
Two more programs that price a small dose the way Medivive does. Both are partners: we may earn a commission if you start care through these links.
Partner
RxSpan MD
$249/mo month to month ($199 on 6-mo)
Standard plan, self-directed low dose
Partner
HealthRX
$190/mo sema · $239/mo tirz (monthly plan)
Standard plan, self-directed low dose
Where this sits
#367 of 548
Ordered with the companies that pay us first, and Medivive is not one of them. A disclosed partition, not a score.
Compare all 548 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What microdosing GLP-1 costs
- Low dose vs full dose
- The true annual cost of a plan
- What a flat price costs at a low dose
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
Strut Health
$99/mo sema lozenge (auto-refill)
FDA warning letter · Strut Health · February 2026 · addressed to Strut Health, LLC dba Strut. Details in our review.
- Vs median
- $76/mo below the $175 median
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the Strut Health review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.